Bertrand Lell
Bertrand Lell
Center de Recherches Medicales de Lambarene
Bestätigte E-Mail-Adresse bei cermel.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10
AHJ van den Biggelaar, R van Ree, LC Rodrigues, B Lell, AM Deelder, ...
The Lancet 356 (9243), 1723-1727, 2000
8642000
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
861*2011
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
RTS, S Clinical Trials Partnership
New England Journal of Medicine 367 (24), 2284-2295, 2012
669*2012
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
The Lancet 386 (9988), 31-45, 2015
5502015
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
4002016
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial
M Adjuik, P Agnamey, A Babiker, S Borrmann, P Brasseur, M Cisse, ...
The Lancet 359 (9315), 1365-1372, 2002
3852002
Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children
AJF Luty, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, B Greve, ...
The Journal of infectious diseases 179 (4), 980-988, 1999
3031999
Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria
AJF Luty, DJ Perkins, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, ...
Infection and immunity 68 (7), 3909-3915, 2000
2852000
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
2752015
Fosmidomycin for malaria
MA Missinou, S Borrmann, A Schindler, S Issifou, AA Adegnika, ...
The Lancet 360 (9349), 1941-1942, 2002
2632002
Fosmidomycin, a novel chemotherapeutic agent for malaria
B Lell, R Ruangweerayut, J Wiesner, MA Missinou, A Schindler, ...
Antimicrobial agents and chemotherapy 47 (2), 735-738, 2003
2622003
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled …
JJ Aponte, D Schellenberg, A Egan, A Breckenridge, I Carneiro, ...
The Lancet 374 (9700), 1533-1542, 2009
2602009
The role of red blood cell polymorphisms in resistance and susceptibility to malaria
B Lell, J May, RJ Schmidt-Ott, LG Lehman, D Luckner, B Greve, ...
Clinical Infectious Diseases 28 (4), 794-799, 1999
2191999
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria.
JFJ Kun, B Mordmuller
The Lancet 351 (9098), 265-265, 1998
2181998
Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
2142015
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
2052014
Clindamycin as an antimalarial drug: review of clinical trials
B Lell, PG Kremsner
Antimicrobial agents and chemotherapy 46 (8), 2315-2320, 2002
1992002
Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon
JFT Kun, RJ Schmidt-Ott, LG Lehman, B Lell, D Luckner, B Greve, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 92 (1 …, 1998
1851998
Placental malaria increases malaria risk in the first 30 months of life
NG Schwarz, AA Adegnika, LP Breitling, J Gabor, ST Agnandji, ...
Clinical Infectious Diseases 47 (8), 1017-1025, 2008
1612008
Malaria chemoprophylaxis with tafenoquine: a randomised study
B Lell, JF Faucher, MA Missinou, S Borrmann, O Dangelmaier, J Horton, ...
The Lancet 355 (9220), 2041-2045, 2000
1542000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20